Molecular Diagnostics (Biocartis / Wondfo) Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Molecular Diagnostics (Biocartis / Wondfo) General Information

Description

A joint venture incorporated to commercialize the fully automated molecular diagnostics platform in mainland China.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • China
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare
Other Healthcare Technology Systems
Corporate Office
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Diagnostics (Biocartis / Wondfo) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Molecular Diagnostics (Biocartis / Wondfo)‘s full profile, request access.

Request a free trial

Molecular Diagnostics (Biocartis / Wondfo) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Molecular Diagnostics (Biocartis / Wondfo)‘s full profile, request access.

Request a free trial

Molecular Diagnostics (Biocartis / Wondfo) FAQs

  • Where is Molecular Diagnostics (Biocartis / Wondfo) headquartered?

    Molecular Diagnostics (Biocartis / Wondfo) is headquartered in China.

  • What industry is Molecular Diagnostics (Biocartis / Wondfo) in?

    Molecular Diagnostics (Biocartis / Wondfo)’s primary industry is Diagnostic Equipment.

  • Is Molecular Diagnostics (Biocartis / Wondfo) a private or public company?

    Molecular Diagnostics (Biocartis / Wondfo) is a Private company.

  • What is Molecular Diagnostics (Biocartis / Wondfo)’s current revenue?

    The current revenue for Molecular Diagnostics (Biocartis / Wondfo) is .

  • Who are Molecular Diagnostics (Biocartis / Wondfo)’s investors?

    Biocartis Group and Guangzhou Wondfo Biotech have invested in Molecular Diagnostics (Biocartis / Wondfo).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process